Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-03-098762
Filing Date
2003-12-23
Accepted
2003-12-23 14:29:35
Documents
9
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 840012
3 AMENDMENT TO AMENDED AND RESTATED BYLAWS dex321.htm EX-3.2.1 4383
4 AMENDMENT TO CONSULTING AGREEMENT BETWEEN SERACARE AND SAM ANDERSON dex10131.htm EX-10.13.1 9355
5 INDENPENDENT AUDITORS' CONSENT dex231.htm EX-23.1 2162
6 CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS dex232.htm EX-23.2 2040
7 302 CERTIFICATION OF CEO dex311.htm EX-31.1 6512
8 302 CERTIFICATION OF CFO dex312.htm EX-31.2 6431
9 906 CERTIFICATION OF CEO dex3211.htm EX-32.1 3025
10 906 CERTIFICATION OF CFO dex322.htm EX-32.2 2971
  Complete submission text file 0001193125-03-098762.txt   879450
Mailing Address 1935 AVENIDA DEL ORO SUITE F OCEANSIDE CA 92056
Business Address 1935 AVENIDA DEL ORO SUITE F OCEANSIDE CA 92056 7608068922
SERACARE LIFE SCIENCES INC (Filer) CIK: 0001156295 (see all company filings)

EIN.: 330056054 | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-33045 | Film No.: 031070554
SIC: 2834 Pharmaceutical Preparations